Tyrosine kinase 3D structures
From Proteopedia
(Difference between revisions)
| Line 376: | Line 376: | ||
*'''Hck tyrosine kinase''' Domains: SH3 81-137; SH2 119-224; SH1 or kinase+C-terminal 225-525; | *'''Hck tyrosine kinase''' Domains: SH3 81-137; SH2 119-224; SH1 or kinase+C-terminal 225-525; | ||
| - | **[[3hck]] - hTK SH2 domain - NMR<BR /> | + | **[[3hck]] - hTK Hck SH2 domain - NMR<BR /> |
| - | **[[1bu1]] - hTK SH3 domain <BR /> | + | **[[1bu1]] - hTK Hck SH3 domain <BR /> |
| - | **[[4hck]], [[5hck]] - hTK SH3 domain - NMR<BR /> | + | **[[4hck]], [[5hck]] - hTK Hck SH3 domain - NMR<BR /> |
| - | **[[2oj2]], [[2oi3]] - hTK SH3 domain + peptide - NMR<BR /> | + | **[[2oj2]], [[2oi3]] - hTK Hck SH3 domain + peptide - NMR<BR /> |
| - | **[[3rbb]], [[3rea]], [[3reb]] - hTK SH3 domain (mutant) + HIV NEF<BR /> | + | **[[3rbb]], [[3rea]], [[3reb]] - hTK Hck SH3 domain (mutant) + HIV NEF<BR /> |
| - | **[[5nuh]] - hTK SH3 domain + SIV NEF<BR /> | + | **[[5nuh]] - hTK Hck SH3 domain + SIV NEF<BR /> |
| - | **[[4orz]] - hTK SH3 domain (mutant) + HIV NEF + single domain antibody<br /> | + | **[[4orz]] - hTK Hck SH3 domain (mutant) + HIV NEF + single domain antibody<br /> |
| - | **[[3nhn]] - hTK SH3-SH2-linker domain <BR /> | + | **[[3nhn]] - hTK Hck SH3-SH2-linker domain <BR /> |
**[[4u5w]] - hTK Hck SH3-SH2 domains + NEF <br /> | **[[4u5w]] - hTK Hck SH3-SH2 domains + NEF <br /> | ||
| - | **[[2c0i]], [[2c0o]], [[2c0t]] - hTK SH3-SH2-SH1 domain + inhibitor<BR /> | + | **[[2c0i]], [[2c0o]], [[2c0t]] - hTK Hck SH3-SH2-SH1 domain + inhibitor<BR /> |
| - | **[[5h0b]], [[5h0e]], [[5h0g]], [[5h0h]] - hTK SH3-SH2-SH1 domain (mutant) + inhibitor<BR /> | + | **[[5h0b]], [[5h0e]], [[5h0g]], [[5h0h]] - hTK Hck SH3-SH2-SH1 domain (mutant) + inhibitor<BR /> |
| - | **[[2hk5]], [[5zj6]] - hTK kinase domain + inhibitor<BR /> | + | **[[2hk5]], [[5zj6]] - hTK Hck kinase domain + inhibitor<BR /> |
| - | **[[1qcf]], [[3vrz]], [[3vs0]], [[3vs3]], [[3vs4]], [[3vs5]], [[3vs6]], [[3vs7]] - hTK SH3-SH2-kinase-C-terminal domain + inhibitor<BR /> | + | **[[1qcf]], [[3vrz]], [[3vs0]], [[3vs3]], [[3vs4]], [[3vs5]], [[3vs6]], [[3vs7]] - hTK Hck SH3-SH2-kinase-C-terminal domain + inhibitor<BR /> |
| - | **[[3vry]], [[3vs1]], [[3vs2]] - hTK SH3-SH2-kinase-C-terminal domain (mutant) + inhibitor<BR /> | + | **[[3vry]], [[3vs1]], [[3vs2]] - hTK Hck SH3-SH2-kinase-C-terminal domain (mutant) + inhibitor<BR /> |
| - | **[[1ad5]] - hTK SH3-SH2-kinase-C-terminal domain + AMPPNP<BR /> | + | **[[1ad5]] - hTK Hck SH3-SH2-kinase-C-terminal domain + AMPPNP<BR /> |
| - | **[[2hck]] - hTK SH3-SH2-kinase-C-terminal domain + quercetin<BR /> | + | **[[2hck]] - hTK Hck SH3-SH2-kinase-C-terminal domain + quercetin<BR /> |
| - | **[[4lud]], [[4lue]] - hTK SH2+SH3+kinase+C-terrminal domain (mutant) + fluorescent compound<br /> | + | **[[4lud]], [[4lue]] - hTK Hck SH2+SH3+kinase+C-terrminal domain (mutant) + fluorescent compound<br /> |
*'''Ack1 tyrosine kinase''' or activated cdc42 kinase 1 | *'''Ack1 tyrosine kinase''' or activated cdc42 kinase 1 | ||
| Line 509: | Line 509: | ||
**[[6nec]], [[6ne7]], [[7ju5]] - hTK Ret kinase domain + cancer drug<br /> | **[[6nec]], [[6ne7]], [[7ju5]] - hTK Ret kinase domain + cancer drug<br /> | ||
**[[4ux8]] - hTK Ret extracellular domain + GFR α 1<br /> | **[[4ux8]] - hTK Ret extracellular domain + GFR α 1<br /> | ||
| - | **[[6gl7]] - hTK Ret extracellular domain + GFR α 2 + neurturin - Cryo EM<br /> | + | **[[6gl7]], [[6q2r]] - hTK Ret extracellular domain + GFR α 2 + neurturin - Cryo EM<br /> |
| + | **[[6q2j]] - hTK Ret extracellular domain + GFR α-like + GDF15 - Cryo EM<br /> | ||
*'''c-Met tyrosine kinase''' see [[Hepatocyte growth factor receptor]] | *'''c-Met tyrosine kinase''' see [[Hepatocyte growth factor receptor]] | ||
Revision as of 10:14, 28 December 2020
3D structures of tyrosine kinase
Updated on 28-December-2020 - For a general description of the protein see Tyrosine kinase
